BASF Restructures Pharmaceuticals; Seeks Agchems Acquisition.

From: Chemical Week | Date: January 26, 2000| Author: Alperowicz, Natasha | Copyright information

Basf is planning to combine its global pharmaceuticals operations into one legal entity that will be headquartered in London. The business will be headed by Thorlef Spickschen, president of BASF's pharmaceuticals division. The new structure, which will begin operating next month, will allow BASF to "respond quickly to changes taking place in the global pharmaceuticals industry," the company says. However, industry sources speculate that BASF may be preparing to spin off or divest t...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

BASF Reorganizes Pharmaceuticals Business.
Chemical Market Reporter ; BASF IS MOVING the headquarters of its pharmaceuticals business to London in a reorganization of its drugs business that could be a prelude to spinning it off. The pharmaceutical ingredients operation, which accounts for 20 percent of the sales of the company's pharmaceuticals division, is being
BASF: Sticking to its Guns.(Interview)
Chemical Week ; Benefits from 'Verbund' BASF IS RESHAPING ITS PORTFOLIO in response to structural changes that have swept the chemical industry since the early l990s. Still, the company has not fundamentally changed course. BASF has stuck to its long-term strategy of Verbund, or total integration, rather than opt
BASF becomes a major U.K. producer: PP acquisition reinforces presence. (acquisition of Imperial Chemical Industries PLC's polypropylene capacity) (Country Focus: United Kingdom)
Chemical Week ; For BASF in the U.K., 1994 is shaping up as a memorable year. On March 1, the company acquired ICI's 150,000-m.t./year polypropylene (PP) capacity at Wilton, Teesside, part of a bigger deal that doubled BASF's PP capacity, to 600,000 m.t./year. Barry Stickings, BASF's regional managing director
BASF Plans to Cut 500 Jobs in Pharma Unit.(Brief Article)(Statistical Data Included)
Chemical Week ; BASF SAYS IT WILL CUT 500 JOBS IN ITS drugs business, 4% of the unit's workforce, by the end of 2001. All of the cuts will take place at BASF Pharma's Ludwigshafen operations, where the number of pharma employees will fall to 1,500. BASF Pharma employs 12,200 worldwide. BASF expects the job cuts to
BASF Launches Cost Savings Plan, Warns on 1999 Earnings.
Chemical Week ; Basf announced a dm900-million ($500 million) cost savings plan last week that will be implemented during 1999. Chairman Jurgen Strube, citing weak economic conditions outside North America, warns that BASF's 1999 earnings will fall and sales will be flat. Of the announced savings, DM250 million